Founded
Address
De Novo Ventures
2180 Sand Hill Road
Suite 300
Menlo Park, CA 94025
United States
Phone
Website
Recent investment activity
KANDO id: 30720
Funding rounds
Actual initial investment stage
Series C (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 64| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Articulinx Inc | Medical device company developing a novel minimally-invasive approach for the treatment of osteoarthritis | N/A | |||
|
|
Asante Solutions Inc | Developing a disposable drug delivery system which initially will be used for insulin delivery for Type I diabetics. | N/A | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series C | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series B | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series A | |||
|
|
Avedro Inc | A medical device company focused on vision correctional devices and has developed innovative ophthalmology solutions for the Lasik and myopia markets. | Series C | |||
|
|
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | |||
|
|
Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series D | |||
|
|
Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series C | |||
|
|
Benvenue Medical Inc | Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. | Series B | |||
|
|
BioParadox Inc | Developing a novel therapy for cardiovascular disease. | N/A | |||
|
|
C2 Therapeutics Inc | N/A | ||||
|
|
CardioThoracic Systems Inc | N/A | ||||
|
|
CAVU Medical Inc | N/A | ||||
|
|
CryoVascular Systems Inc | Medical device company for peripheral arterial disease. | N/A | |||
|
|
EBR Systems Inc | A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation | Series C | |||
|
|
EBR Systems Inc | A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation | Venture | |||
|
|
Facet Solutions | Developing surgical devices to treat spinal stenosis. | Series C | |||
|
|
Facet Solutions | Developing surgical devices to treat spinal stenosis. | Series B | |||
|
|
FlowMedica Inc | Developer of a renal infusion catheter for selective delivery of pharmaceuticals to the renal circulation. | Series D | |||
|
|
Informed Medical Communications Inc | Medical information services provider that enables biopharmaceutical companies to market directly to physicians and patients. | N/A | |||
|
|
InSound Medical Inc | Medical device company focused on the development and sale of next generation hearing aid solutions. | Series E | |||
|
|
InSound Medical Inc | Medical device company focused on the development and sale of next generation hearing aid solutions. | Series D | |||
|
|
Integrated Vascular Systems Inc | Medical device company developing devices to treat congestive heart failure. | N/A | |||
|
|
iScience Interventional Inc | Leading the discovery and development of the product platforms used in Interventional Ophthalmology | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Frederick Dotzler (founder) | [email protected] | |||
| Richard Ferrari (founder) | [email protected] | |||
| Joe Mandato | [email protected] |
Former team members
| Employee | Company | Position | |||
|---|---|---|---|---|---|
| David Mauney | Thrive Agrobiotics Inc | Director
Responsibilities: Executive Officer |
|||
| David Mauney | Koch Disruptive Technologies | ||||
| Cathy Minshall | Emergence Capital Partners LLC | [email protected] |